Followers | 172 |
Posts | 10850 |
Boards Moderated | 1 |
Alias Born | 12/08/2016 |
![](https://investorshub.advfn.com/uicon/586823.png?cb=1647346952)
Friday, March 15, 2019 8:27:30 PM
Have a great weekend Flex! Check this out my friend... Arrayit Corp’s (ARYC) finger stick test is a first of its kind medical breakthrough. Not only is it easy and painless, but it also provides an allergy scale report. The old skin test could not do this, therefore, the patient’s did not know how allergic they were to a specific allergen.
Arrayit’s breakthrough technology is key with immunotherapy treatment when adding dosage amounts. These dosage amounts are slowly increased depending on the continuous finger stick test results as your immune system strengthens.
Allovate Therapeutics/Intrommune Therapeutics?
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_Corporation_Announces_/arrayit_corporation_announces_allergy_testing_partnerships_with_.html
Allovate Therapeutics (“Allovate®”) announce that they have signed an exclusive agreement to combine PAS’s simple and minimally invasive fingerstick allergy test (the “Test”) and Allovate’s Allerdent®, a patented toothpaste-based system for the delivery of allergy immunotherapy (the “Treatment”) to enable primary care physicians to offer personalized allergy care.
https://www.globenewswire.com/news-release/2017/12/19/1266153/0/en/New-Test-and-Treatment-Allergy-Program-Enables-All-Physicians-To-Provide-Convenient-And-Effective-Allergy-Care.html
PAS program are now able to test allergy sufferers for specific allergies with a simple and safe fingerstick blood test, exclusive to the PAS program, requiring only drops of blood. The dried blood samples are sent to a PAS laboratory partner to be assessed for 145 different respiratory and food allergy sensitivities using a proprietary macroarray based technology. The laboratory sends the diagnostic report back to the clinician to be reviewed with the patient. The physician can then prescribe a personalized and convenient allergy immunotherapy for respiratory allergies in the form of a specialized toothpaste
https://www.biospace.com/article/releases/allovate-release-new-test-and-treatment-allergy-program-enables-all-physicians-to-provide-convenient-and-effective-allergy-care/
*Note: The dried blood samples are sent to a PAS laboratory partner
July 2018 - Pre-IND Meeting Expected With the U.S. FDA
https://netcapital.com/companies/intrommune
Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
Kroger’s The Little Clinic:
https://www.bing.com/videos/search?q=allerdent&view=detail&mid=508D4C15923F0BE5040E508D4C15923F0BE5040E&FORM=VRRTAP
“The retail chain, which reports revenues exceeding $50,000,000,000 ($50 billion US dollars) annually, has more than 2,000 locations nationwide.”
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_Corporation_Completes_/arrayit_corporation_completes_allergy_testing_pilot_program_for_.html
The Kroger Co. operates nearly 2,200 retail Pharmacies in 37 states, each staffed with caring professionals dedicated to helping people lead healthier lives.
In 2017, Kroger generated 62.38 billion U.S. dollars with non-perishable items. Kroger is a supermarket chain operating in the United States.
9-10-18: Arrayit business development team signs non-disclosure agreement with the global head of business development and mergers and acquisitions of a major allergy testing company headquartered in the European Union and advancing allergy healthcare globally http://arrayit.com/Clinical/clinical.html …
Global Expansion:
Intrommune Therapeutics has exclusively licensed the world-wide rights to this intellectual property from Allovate Therapeutics to develop the OMIT platform for the treatment of food allergies. Over 15 million people in the U.S. and 17 million in Europe have food allergies. There is currently no FDA approved treatment for any food allergy.
https://www.benzinga.com/pressreleases/19/03/g13327065/allovate-therapeutics-announces-grant-of-european-patent-covering-oral
Food allergy is a serious and potentially life-threatening medical condition affecting 15 million people in the United States, including approximately 8% of children and 5% of adults. 17 million more deal with the condition in the European Union.
Institutional Investors & Hedge Funds:
Arrayit signs capital financing agreement with a top buy-side analyst at a leading corporate intelligence firm headquartered in London UK with offices in New York and providing buy-side intelligence to high net worth retail investors, institutional investors and hedge funds.
Arrayit senior management completes analyst call with top buy side analyst at the prestigious Alpha Deal Group headquartered in New York NY USA and providing premium independent due diligence for high net-worth retail, instituional and hedge fund customers (link: http://www.alphadealgroup.com) alphadealgroup.com
Allovate Therapeutics/Intrommune Therapeutics:
https://www.globenewswire.com/news-release/2018/11/08/1648621/0/en/Intrommune-Therapeutics-Announces-First-Close-of-Series-A-Preferred-Equity-Financing-and-Successful-Close-of-Crowdfunding-Financing-Campaign-to-Support-New-Peanut-Allergy-Treatment.html
Arrayit Corp (ARYC) share price could explode straight to multi-dollars soon. There is a lot of talk & several major news channel videos about the Allerdent toothpaste. This immunotherapy treatment needs the finger stick test in order to measure dosage amount.
Arrayit’s breakthrough technology is key with immunotherapy treatment when adding dosage amounts. These dosage amounts are slowly increased depending on the continuous finger stick test results as your immune system strengthens.
Allovate Therapeutics/Intrommune Therapeutics?
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_Corporation_Announces_/arrayit_corporation_announces_allergy_testing_partnerships_with_.html
Allovate Therapeutics (“Allovate®”) announce that they have signed an exclusive agreement to combine PAS’s simple and minimally invasive fingerstick allergy test (the “Test”) and Allovate’s Allerdent®, a patented toothpaste-based system for the delivery of allergy immunotherapy (the “Treatment”) to enable primary care physicians to offer personalized allergy care.
https://www.globenewswire.com/news-release/2017/12/19/1266153/0/en/New-Test-and-Treatment-Allergy-Program-Enables-All-Physicians-To-Provide-Convenient-And-Effective-Allergy-Care.html
PAS program are now able to test allergy sufferers for specific allergies with a simple and safe fingerstick blood test, exclusive to the PAS program, requiring only drops of blood. The dried blood samples are sent to a PAS laboratory partner to be assessed for 145 different respiratory and food allergy sensitivities using a proprietary macroarray based technology. The laboratory sends the diagnostic report back to the clinician to be reviewed with the patient. The physician can then prescribe a personalized and convenient allergy immunotherapy for respiratory allergies in the form of a specialized toothpaste
https://www.biospace.com/article/releases/allovate-release-new-test-and-treatment-allergy-program-enables-all-physicians-to-provide-convenient-and-effective-allergy-care/
*Note: The dried blood samples are sent to a PAS laboratory partner
July 2018 - Pre-IND Meeting Expected With the U.S. FDA
https://netcapital.com/companies/intrommune
Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval. pic.twitter.com/KPkURL4Mxy
— Arrayit Corporation (@arrayit) July 3, 2018
Kroger’s The Little Clinic:
https://www.bing.com/videos/search?q=allerdent&view=detail&mid=508D4C15923F0BE5040E508D4C15923F0BE5040E&FORM=VRRTAP
“The retail chain, which reports revenues exceeding $50,000,000,000 ($50 billion US dollars) annually, has more than 2,000 locations nationwide.”
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_Corporation_Completes_/arrayit_corporation_completes_allergy_testing_pilot_program_for_.html
The Kroger Co. operates nearly 2,200 retail Pharmacies in 37 states, each staffed with caring professionals dedicated to helping people lead healthier lives.
In 2017, Kroger generated 62.38 billion U.S. dollars with non-perishable items. Kroger is a supermarket chain operating in the United States.
9-10-18: Arrayit business development team signs non-disclosure agreement with the global head of business development and mergers and acquisitions of a major allergy testing company headquartered in the European Union and advancing allergy healthcare globally http://arrayit.com/Clinical/clinical.html …
Global Expansion:
Intrommune Therapeutics has exclusively licensed the world-wide rights to this intellectual property from Allovate Therapeutics to develop the OMIT platform for the treatment of food allergies. Over 15 million people in the U.S. and 17 million in Europe have food allergies. There is currently no FDA approved treatment for any food allergy.
https://www.benzinga.com/pressreleases/19/03/g13327065/allovate-therapeutics-announces-grant-of-european-patent-covering-oral
Food allergy is a serious and potentially life-threatening medical condition affecting 15 million people in the United States, including approximately 8% of children and 5% of adults. 17 million more deal with the condition in the European Union.
Institutional Investors & Hedge Funds:
Arrayit signs capital financing agreement with a top buy-side analyst at a leading corporate intelligence firm headquartered in London UK with offices in New York and providing buy-side intelligence to high net worth retail investors, institutional investors and hedge funds.
Arrayit senior management completes analyst call with top buy side analyst at the prestigious Alpha Deal Group headquartered in New York NY USA and providing premium independent due diligence for high net-worth retail, instituional and hedge fund customers (link: http://www.alphadealgroup.com) alphadealgroup.com
Allovate Therapeutics/Intrommune Therapeutics:
https://www.globenewswire.com/news-release/2018/11/08/1648621/0/en/Intrommune-Therapeutics-Announces-First-Close-of-Series-A-Preferred-Equity-Financing-and-Successful-Close-of-Crowdfunding-Financing-Campaign-to-Support-New-Peanut-Allergy-Treatment.html
Arrayit Corp (ARYC) share price could explode straight to multi-dollars soon. There is a lot of talk & several major news channel videos about the Allerdent toothpaste. This immunotherapy treatment needs the finger stick test in order to measure dosage amount.
All my posts are in my opinion only.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.